Smith & Nephew Plc Director/PDMR Shareholding

RNS Number : 9151P

Smith & Nephew Plc

24 May 2024

SMITH & NEPHEW PLC

24 May 2024

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

Reason for the notification
Initial notification /Amendment	Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name	Smith & Nephew plc
LEI	213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument	Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code	ISIN: GB0009223206
Nature of the transaction	Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2023 final dividend payment on 22 May 2024.
Date of Transaction	2024 - 05 - 22
Place of Transaction	London Stock Exchange (XLON)

Name (Position)	Director / PDMR	Price	Volume	Aggregated information
Helen Barraclough (Group General Counsel and Company Secretary)	PDMR	10.1921	627.51301	N/A Single Transaction
Craig Gaffin (President, Global Orthopaedics)	PDMR	10.1921	132.42844	N/A Single Transaction
Paul Connolly (President, Global Operations)	PDMR	10.1921	290.35933	N/A Single Transaction
Phil Cowdy Chief Corporate Development & Corporate Affairs Officer	PDMR	10.1921	158.47807	N/A Single Transaction
Mizanu Kebede (Chief Quality & Regulatory Affairs Officer)	PDMR	10.1921	166.31452	N/A Single Transaction
Deepak Nath (Chief Executive Officer)	Director	10.1921	2,866.48338	N/A Single Transaction
Alison Parkes (Chief Compliance Officer)	PDMR	10.1921	78.39762	N/A Single Transaction
Scott Schaffner (President, Sports Medicine)	PDMR	10.1921	1,168.88629	N/A Single Transaction
Vasant Padmanabhan (President Research & Development and ENT)	PDMR	10.1921	196.76528	N/A Single Transaction

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFVEESISFIS

Smith & Nephew (LSE:SN.)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024